The 2.0-Å resolution x-ray crystal structure of a novel trimeric antibody fragment, a ''triabody,'' has been determined. The trimer is made up of polypeptides constructed in a manner identical to that previously described for some ''diabodies'': a V L domain directly fused to the C terminus of a V H domain-i.e., without any linker sequence. The trimer has three Fv heads with the polypeptides arranged in a cyclic, head-to-tail fashion. For the particular structure reported here, the polypeptide was constructed with a V The antigen-binding site in antibodies is formed by the hypervariable loop regions (complementarity-determining regions, CDRs) of V H and V L domain pairs to yield a continuous surface mounted on a rigid scaffold provided by the framework regions of these domains. The ultimate diversity of antigen binding is determined by the structural diversity of this surface. From extensive analysis of structures of antibody fragments, it is clear that there is only a small set of ''canonical'' main-chain loop conformations for five of the six CDRs (1, 2). However, CDR3 of the V H domain, located at the center of the antigenbinding site, has defied attempts at classification due to its large variability in length and sequence, resulting from the junctional diversity generated in somatic V H gene assembly. Furthermore, a range of conformational changes in antigenbinding sites can occur upon antigen binding (3-8). These changes range from minor side-chain adjustments to major rearrangements in the main-chain loop conformations of V H CDR3, as well as to changes in the relative orientation of the V H and V L domains (3). Furthermore, the biphasic kinetics of some antibodies in response to antigen binding suggest that there is conformational heterogeneity even prior to antigen binding (9, 10).
The antigen-binding site in antibodies is formed by the hypervariable loop regions (complementarity-determining regions, CDRs) of V H and V L domain pairs to yield a continuous surface mounted on a rigid scaffold provided by the framework regions of these domains. The ultimate diversity of antigen binding is determined by the structural diversity of this surface. From extensive analysis of structures of antibody fragments, it is clear that there is only a small set of ''canonical'' main-chain loop conformations for five of the six CDRs (1, 2) . However, CDR3 of the V H domain, located at the center of the antigenbinding site, has defied attempts at classification due to its large variability in length and sequence, resulting from the junctional diversity generated in somatic V H gene assembly. Furthermore, a range of conformational changes in antigenbinding sites can occur upon antigen binding (3) (4) (5) (6) (7) (8) . These changes range from minor side-chain adjustments to major rearrangements in the main-chain loop conformations of V H CDR3, as well as to changes in the relative orientation of the V H and V L domains (3) . Furthermore, the biphasic kinetics of some antibodies in response to antigen binding suggest that there is conformational heterogeneity even prior to antigen binding (9, 10) .
A fundamental component of antibody diversity arises from random V H -V L pairings. ''Promiscuous'' V H -V L pairings have also been observed in phage-displayed antibody libraries and have been exploited for affinity maturation in vitro (11) or ''humanizing'' antibodies (12, 13) . It has been anticipated that novel V H -V L pairings could influence the conformations of the CDR loops (14) . We have determined the structure of an Fv consisting of a V H domain from one antibody paired with a V L domain from an unrelated antibody. This structure shows a large rearrangement of the antigen-binding region of the V H domain and reinforces that the expressed structural diversity is not simply related to the product of the sequence diversity of the V H and V L domains considered independently.
An unrelated but important objective of our work was to show that single chain Fv fragments with very short linkers between the V H and V L domains (zero residues in this instance) can form stable trimers. Previously, we described the structure of a dimeric antibody construct known as a ''diabody'' (15) . In such a construct V H and V L domains are fused to each other with a linker sequence too short to permit intramolecular pairing of the domains, forcing formation of dimers. In several diabody preparations, we have noticed higher-order oligomers. For the B1-8͞NQ11 construct in which the V H domain of B1-8 is directly fused to the N terminus of the V L domain of NQ11, the preparation consisted predominantly of oligomers with a gel-filtration estimated size consistent with a trimer. We report here the structure of a trimeric antibody fragment.
MATERIALS AND METHODS
Vector Construction. An antibody fragment was constructed so that the V H domain of antibody B1-8 was directly fused to the V L domain of antibody NQ11 as illustrated in Fig. 1 . Because the V H and V L domains are directly fused to each other, it is not sterically possible for the V H and V L domains in a single polypeptide to pair with each other. Consequently, the polypeptides form oligomers in which the V H -V L pairing is achieved intermolecularly (16) (17) (18) (19) . This type of multivalent antibody fragment has been referred to as a diabody (15, 17) , although dimeric, trimeric, and higher-order multimers can be isolated (16) (17) (18) (19) .
Expression and Purification of Antibody Fragments. The multivalent antibody fragment B1-8͞NQ11 was expressed in Escherichia coli. The protein was purified from culture supernatant using three chromatagraphic steps: Ni 2ϩ -NTA agarose (Qiagen, Chatsworth, CA) affinity purification, gel filtration with a HiLoad 16͞60 Superdex 75 column (Pharmacia) equilibrated with 20 mM Tris⅐HCl (pH 8.0), 0.1 M NaCl, and finally a salt gradient on a MonoQ HR 5͞5 column equilibrated in 20 mM Tris⅐HCl (pH 8.0). Gel filtration analysis indicated that dimers, trimers, and higher-order oligomers are present. The trimeric fraction was pooled and applied to the MonoQ. The protein was concentrated to 18.7 mg͞ml and stored at 4°C. Our purification protocol and structure determination focused on a trimeric or ''triabody'' species.
Crystallization. Initial small crystals appeared at 4°C in 30% 2-propanol, 0.1 M Na cacodylate (pH 6.5), and 0.2 M Na citrate. Subsequently, pre-equilibrated drops were microseeded. A typical crystal had dimensions of 0.2 mm ϫ 0.2 mm ϫ 0.1 mm. The crystals have R3 symmetry with unit cell dimensions a ϭ 136.32 Å, c ϭ 74.8 Å. The Matthews coefficient (V M ) of the crystals is 2.4 Å 3 ͞Da. X-Ray Diffraction Data Collection. Data from a single crystal were collected at the Daresbury Synchrotron Station 9.6 at a wavelength of 0.882 Å with a MAR-Research (Hamburg, Germany) 300-mm image plate. Data were collected to a resolution of 1.9 Å. The crystal for data collection was flash frozen in a nitrogen cold stream at 95 K. The freezing solution was the same solution as used for growing the triabody crystals with the addition of 20% (wt͞vol) 2-methyl-2,4-pentanediol. Diffraction data were processed and refined with the program MOSF LM (20) . Data sorting, scaling and merging were done with the CCP4 package (21) . There were a total of 95,579 observations of 33,839 unique reflections giving an average redundancy of 2.8. Data were 96.6% complete to 1.9 Å. The overall R sym was 0.053 based on intensities with an R sym of 0.174 for the data from 2.0 Å to 2.05 Å. (22) . An initial rotation function was calculated using search models derived from a library of 37 Fv structures. The 10 highest rotation function solutions for each Fv were used for translation function searches. Monoclonal antibody fragment JE142 (Protein Data Bank entry 1jel) yielded the highest correlation coefficient (21.9%) and lowest R factor (51.8%) and was used for the next step of the analysis. This initial rotation͞translation solution was refined as a rigid-body and was subsequently fixed for a second round of the translation function searches to locate a second molecule. In the second round of the translation function searches, all of the 37 Fv structures were again used. The second round of translation function searches yielded a correlation coefficient of 29.1% and an R factor of 49.8%. Again, JE142 was the Fv that gave the strongest signal. The two molecules in the asymmetric unit were refined as four rigid-bodies (two V H and two V L domains). This yielded a correlation coefficient of 61.3% and R factor of 36.5%. Structure Refinement. The structure was refined using data to 2.0-Å resolution. Unrestrained refinement was carried out with the program ARP (23) to generate an electron density map that was used for initial model building. An initial model was built using the program O (24) . Noncrystallographic symmetry restrained positional and temperature factor refinement were carried out with the program X-PLOR. A few cycles of X-PLOR (25) least-squares refinement (using all data not flagged as ''free'' from 6.0 Å to 2.0 Å resolution, 31,030 reflections) alternated with model rebuilding into difference electron density maps produced as a result of unrestrained ARP refinement, yielded an R factor of 0.235 and a free R factor of 0.262 (using 5% of the data, 1,649 reflections). After switching off the NCS restraints, the R factor was 0.187 with a free R factor of 0.230. Simulated annealing with X-PLOR did not improve the free R factor. For one molecule in the asymmetric unit, residues 101-108 of the V H domain are well defined (Fig. 2) . For the other molecule in the asymmetric unit, this region is disordered. The myc and (His) 6 tags at the C terminus of the polypeptide are not visible for either of the molecules in the asymmetric unit. The junction between the N-terminal V H and C-terminal V L domains is well ordered and clearly discernible for both molecules in the asymmetric unit. The electron density is disordered for the main-chain in region Pro H41 to Arg H43 of both polypeptides in the asymmetric unit. The model has good stereochemistry as evaluated by PROCHECK (26) . Root-mean squared deviations from ideal geometry are 0.008 Å, 1.41°, and 26.9°for bond lengths, bond angles, and dihedral angles, respectively.
RESULTS AND DISCUSSION
The Structure of a Trimeric, Combinatorial Antibody Fragment. The overall fold of the antibody fragment is of a type that has been referred to as a domain-swapped trimer (27) . The trimer has three Fv heads with the polypeptides in the trimer arranged in a cyclic head-to-tail fashion. The V H domain of each polypeptide pairs with the V L domain of a neighboring polypeptide in the trimer giving rise to three antigen-binding sites (Fig. 3) the structure of NQ11͞B1-8 and the structure of a diabody reported previously (15) show that this type of antibody fragment readily forms domain-swapped dimers and trimers.
The present structure may be used as a blueprint for the design and construction of trivalent or even trispecific antibody fragments. Triabodies could bind three different or identical epitopes on the same molecule leading to higher specificities and higher functional affinities. Furthermore, by cross-linking three different types of antigens trispecific triabodies might, in principle, be useful immunotherapeutic agents by retargeting resting cytotoxic lymphocytes in a manner that has been demonstrated for other trispecific antibody fragments (28, 29) . However, because of random pairing in a triabody system expressing three different polypeptides, only a small fraction of correctly paired, trispecific triabodies would be produced. The fraction of trispecific triabody might be improved by engineering specificity into the V H -V L domain interface as has been described for diabodies (30) .
The polypeptide forming the trimer used in this study has a V domain from the NQ11 anti-hapten phOx (2-phenyl-5-oxazolone) antibody fused to the V H domain from an unrelated antibody, a B1-8 anti-hapten NIP (4-hydroxy-5-iodo-3-nitrophenyl acetyl) antibody. Although the ''combinatorial'' Fvs in the triabody we have crystallized are not capable of binding either of the haptens for which the parental antibodies were specific, they have allowed us to examine the influence of the V L domain on the conformations of the CDRs of the V H domain. The Effect of Exchanging One V L Domain for Another on the V H Conformation. The structure of Fv B1-8 fragment had been solved previously both in the presence and absence of antigen (T. Simon and K. Henrick, personal communication). The structure of a very closely related NIP-binding Fab, N1G9, which differs by only one conservative replacement in the V H domain (V116L), has also been determined both in the presence and absence of antigen (31) (Protein Data Bank entries 1 ngp and 1 ngq) and these four structures are nearly identical to each other. We have compared the structure of the B1-8 V H domain paired to the B1-8 V chain with the structure of it paired to the V domain from NQ11. Inspection of the combinatorial B1-8͞NQ11 Fv structure shows that substitution of one V L domain for another had little influence on the conformations of the first two hypervariable loops of the V H domain but had a profound influence on V H CDR3 with deviations of 0.17 Å, 0.15 Å, and 1.8 Å for H1, H2, and H3, respectively.
The triabody context per se in which the combinatorial Fvs were expressed does not appear to have an influence on the conformation of the CDRs. As was observed for a diabody (Fig. 4) . The change in orientation that we have observed upon exchanging one V L domain for an unrelated one is similar to the largest of the antigen induced interdomain movements that have been reported: 16°for the HIV-1 neutralizing Fab 50.1 and 7.5°for the anti-DNA Fab BV04 (32) .
The residues involved in the V H -V L interface are quite common in comparison with other antibodies (Table 1) . Among these interface residues are most of the residues of the V H CDR3 loop. The extent of the V H -V L interface is similar to the interface found in Fv B1-8 and fairly large (1,720 Å 2 ) relative to other antibodies (solvent accessible surface area buried in the interface calculated using a 1.4-Å probe and the default atomic radii of the program GRASP). Most of the V H -V L interactions in B1-8 involve residues in L3 and H3 (31) . The residues of the V H domain that are involved in the interface of B1-8͞NQ11 are generally the same residues involved in the B1-8 interface (Fig. 1) . Those that differ between B1-8͞NQ11 and B1-8 are residues packing against CDR3 of the V L domain. These differences in packing are not surprising. All of the mouse V domains whose structures have been determined, including B1-8, have similar L3 conformations, and these differ from canonical ''type-1'' L3 conformation found in V s such as that of B1-8͞NQ11 (1).
Rearrangement of the V H CDR3 Loop. The V H CDR3 loop, residues 99 H -109 H , of the triabody has its tip twisted with respect to its conformation in Fv B1-8 (Fig. 5) . The twist of the loop is accomplished by a flip of the main-chain dihedral angles for residues half-way between the base and the tip, Gly H103 , Ser H104 , and Ser H105 [sequential triabody numbering ( Fig. 1)] ( Table 2 ). The conformational change in H3 results in main-chain deviations of up to 5.6 Å (C ␣ of Gly H103 ) and a maximal side-chain deviation of 13.9 Å (OH of Tyr H106 ). The 94 (1997) magnitude of this rearrangement is similar to the largest of the conformational changes induced by antigen binding (33) .
A notable consequence of the conformational change of H3 is that the side chain of Tyr H106 is in a radically different position than in B1-8. The change in the position of Tyr H106 appears to be dictated by the space available for it against the surface of the V L domain (Fig. 5a ). In the B1-8 structure, both in the presence and absence of antigen, Tyr H106 is packed against the V L domain filling the space adjacent to Ala L57 [B1-8 numbering (Fig. 1) ]. In the B1-8͞NQ11 structure, the analogous space is occupied by Phe L60 and by the side chain of Tyr L101 from the C terminus of L3 thereby occluding Tyr H106 from this site. Conversely, the cavity adjacent to Gly L96 is filled by the side chain of Tyr H106 in B1-8͞NQ11 whereas in B1-8, the analogous volume is occupied by the side chain of Trp L93 . The structures suggest that the H3 loop is able to take on very different conformations in response to the surface provided by the V L domain and that the interactions of Tyr H106 may be of is a feature of all of the mouse V germ-line sequences. It is fairly common for V sequences to have a small residue at the analogous position, and it is a pocket formed by a glycine at this position in the NQ11 V domain that has allowed the side chain of Tyr H106 to change its position so dramatically.
The conformation of the V H CDR3 in B1-8͞NQ11 is stabilized by hydrogen bonds with residues in the framework and L3 of the V L domain: the OH of Tyr H106 interacts with the side chain of Tyr L101 and the carbonyl oxygen of Gly L96 , and the amide N of Phe H107 interacts with the OH of Tyr L41 . These interactions are not present in B1-8. Instead, in the B1-8 structure, V H CDR3 is stabilized by hydrogen bonds with the framework and hypervariable loops L1 and L2 (Fig. 5) . The canonical conformation of L1 unique to mouse V domains (34) makes it likely that H3-L1 interactions will be altered upon replacing a V domain with a V domain.
Combinatorial V H -V L pairing constitutes a fundamental source of antibody diversity in the immune response. However, the B1-8͞NQ11 structure provides evidence that the expressed diversity is not simply related to the genetic diversity. The exchange of one variable domain for another through the process known as ''receptor editing'' may be an important feature of development of the Ig repertoire (35, 36) . Thus a novel V H -V L pairing may ''remodel'' the binding site through conformational changes of V H CDR3. This may abolish antigen binding, but it may also allow the immune response to escape from a dead-end antigen-binding site that cannot be improved beyond a certain limit by somatic mutation, providing a fresh start with an entirely reshaped antigen-binding site. Plasticity of the H3 loop may be an important source of diversity of antigen-binding sites and may be an important consideration for antibody design and structure prediction.
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